MML Investors Services’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
207,378
+13,072
| +7% | +$116K | 0.01% | 1297 |
|
|
2025
Q1 | $1.52M | Buy |
194,306
+27,000
| +16% | +$211K | 0.01% | 1335 |
|
|
2024
Q4 | $1.76M | Buy |
167,306
+30,950
| +23% | +$325K | 0.01% | 1188 |
|
|
2024
Q3 | $1.79M | Buy |
136,356
+16,500
| +14% | +$216K | 0.01% | 1152 |
|
|
2024
Q2 | $1.69M | Buy |
119,856
+17,925
| +18% | +$252K | 0.01% | 1119 |
|
|
2024
Q1 | $1.72M | Buy |
101,931
+27,050
| +36% | +$457K | 0.01% | 1116 |
|
|
2023
Q4 | $1.06M | Buy |
74,881
+2,294
| +3% | +$32.4K | ﹤0.01% | 1325 |
|
|
2023
Q3 | $748K | Buy |
72,587
+21,987
| +43% | +$227K | ﹤0.01% | 1398 |
|
|
2023
Q2 | $834K | Buy |
50,600
+15,500
| +44% | +$255K | ﹤0.01% | 1325 |
|
|
2023
Q1 | $322K | Buy |
35,100
+1,000
| +3% | +$9.17K | ﹤0.01% | 1638 |
|
|
2022
Q4 | $244K | Buy |
34,100
+1,000
| +3% | +$7.16K | ﹤0.01% | 1904 |
|
|
2022
Q3 | $166K | Hold |
33,100
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q2 | $81K | Buy |
33,100
+5,100
| +18% | +$12.5K | ﹤0.01% | 1986 |
|
|
2022
Q1 | $191K | Buy |
+28,000
| New | +$191K | ﹤0.01% | 1979 |
|